Case Western Reserve University developed the gadolinium material, which is expected to be tested in 30 healthy participants beginning later this month.

The caution comes just one week after a pair of imaging experts said it's time the field reconsiders radiologists' role in overseeing adverse contrast reactions.

Physicians face a similar risk of injury on their drive to imaging centers as patients receiving contrast for exams, two experts argued in JACR.

Researchers expect the Supramolecular Amorphous-like Iron Oxide agent to play a vital role in diagnosing stroke, heart attack, dementia, and other similar conditions.

The approach is a promising tool to safely and effectively evaluate donor liver perfusion, researchers explained in the European Journal of Radiology.

The manganese-based contrast was also expelled more rapidly and completely from the body compared to other imaging agents.

The approach accurately detected facial muscle abnormalities associated with the condition, according to research published in Clinical Radiology.

Radiologists signed off on the exam, but never took the proper steps to determine the 91-year-old's contrast risks.